Clinical trial · Observational
Longitudinal Follow up of Patients With Pleural Effusion
Longitudinal Follow up of Patients With Pleural Effusion in South Korea
NCT04670562CI-TRIAL-00059241unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to evaluate the clinical course of patients diagnosed with pleural effusion and determine various clinical factors and biomarkers associated that can predict the diagnosis and clinical outcome and prognosis of patients with pleural effusion due to specific causes.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pleural Effusion, Malignant | — | UNRESOLVED | — |
| Prognosis | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Mortality
- timeFrame
- From date of diagnosis of malignant pleural effusion until the date of death, assessed up to 36 months.
- description
- Mortality
Secondary outcomes (1)
- measure
- Disease progression
- timeFrame
- From date of diagnosis of malignant pleural effusion until the date of first documented disease progression, assessed up to 36 months.
- description
- Progression of original malignancy or new metastasis occured
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients presented with pleural effusion * Patients who undergo thoracentesis and fluid analysis for diagnosis and management Exclusion Criteria: * Patients who refuse to be enrolled
References
Publications (0)
Data not yet available
No reference posted for this study.